Abatacept for acute graft-versus-host disease prophylaxis after unrelated donor hematopoietic cell transplantation
Original Publication Date
Article Source
External Web Content
Key Points This study illustrates the survival benefits of abatacept combined with CNI/MTX in patients with hematologic malignancies undergoing HCT. The addition of abatacept may provide an approach for alternative donor pool expansion when HLA-identical sibling donors are…
